South & Central America Blood Irradiation Market

The blood irradiation market in South & Central America is expected to grow from US$ 4.63 million in 2022 to US$ 6.99 million by 2028. It is estimated to grow at a CAGR of 7.1% from 2022 to 2028.

Technological Advancements and Product Launches

The trends in the healthcare industry are changing drastically with constant development in technology and innovation, enhancing healthcare services and quality of care. Various market players are operating regionally and striving to acquire the largest market share, followed by the rising demand for blood irradiation, especially for immunocompromised patients. This is increasing the research and development activities and investments to innovate novel blood irradiation devices and technologies. Furthermore, there have been advancements in alternative technologies such as proton and ion beam therapies that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues. Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors. These technological advancements and development have a high precision rate with reduced side effects, likely to create ample opportunities for the blood irradiation market. Thus, an increase in technological advancements, product launches, and the increasing use of alternative technologies are expected to support the growth of the blood irradiation market in the coming years.

Market Overview

The South & Central America blood irradiation market has been segmented into Brazil, Argentina, and the Rest of South & Central America. The region held the smallest share of the market in 2021. However, the blood irradiation market in the region is expected to grow with the increasing number of surgeries, surge in various research activities, and rising healthcare expenditure in the region in the coming years. Additionally, Brazil has made huge strides in healthcare sector owing to increasing healthcare expenditure. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America and spends 9.1 percent of its GDP in healthcare. The blood irradiation market in Brazil is expected to flourish owing to factors such as, increasing surgeries, surge in research studies in the country, and rising healthcare expenditure by the country.

 South & Central America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Blood Irradiation Market Segmentation

The South & Central America blood irradiation market is segmented into type, indication, end user, and country.

• Based on type, the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.
• Based on indication, the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.
• Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.
• Based on country, the market is segmented into Brazil, Argentina and Rest of South & Central America. Brazil dominated the market share in 2022.

Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the region.  

South & Central America Blood Irradiation Market Strategic Insights

South & Central America Blood Irradiation Market Segmentation Analysis

South & Central America Blood Irradiation Market Report Highlights

South & Central America Blood Irradiation Report Scope

South & Central America Blood Irradiation Market Country and Regional Insights